Immutep Limited ( PRRUF) - Key Metrics
PRRUF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.03 | -$0.02 | -$0.02 |
| 2025Q4 | $0 | -$0.03 | -$0.02 | -$0.02 |
| 2025Q2 | $0 | -$0.02 | -$0.02 | -$0.02 |
| 2024Q4 | $0 | -$0.02 | -$0.01 | -$0.01 |
| 2024Q2 | $0 | -$0.02 | $0 | $0 |
PRRUF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | -3.40 |
| 2025Q4 | ? | -2.24 |
| 2025Q2 | ? | -5.93 |
| 2024Q4 | ? | -4.38 |
| 2024Q2 | ? | -4.57 |
PRRUF
Price: $0.05
52 week price:
Earnings Per Share: -0.03 USD
P/E Ratio: -8.33
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 73.7 million